(Q35528710)

8 August 2017

A pilot trial of deferiprone for neurodegeneration with brain iron accumulation (English)

1 reference

neurodegeneration with brain iron accumulation

8 August 2017

0 references

1 reference

2

Giovanni Cossu

1 reference

8 August 2017

Giovanni Abbruzzese

1

1 reference

8 August 2017

Manuela Balocco

3

1 reference

8 August 2017

Roberta Marchese

4

1 reference

8 August 2017

Daniela Murgia

5

1 reference

8 August 2017

Maurizio Melis

6

1 reference

8 August 2017

Renzo Galanello

7

1 reference

8 August 2017

Susanna Barella

8

1 reference

8 August 2017

Gildo Matta

9

1 reference

8 August 2017

Uberto Ruffinengo

10

1 reference

8 August 2017

Ubaldo Bonuccelli

11

1 reference

8 August 2017

Gian Luca Forni

12

1 reference

8 August 2017

language of work or name

1 reference

26 July 2011

1 reference

8 August 2017

1 reference

8 August 2017

96

1 reference

8 August 2017

11

1 reference

8 August 2017

1708-1711

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208690

8 August 2017

1 reference

Analysis of nucleotide variations in genes of iron management in patients of Parkinson's disease and other movement disorders.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208690

Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208690

Clinical and genetic delineation of neurodegeneration with brain iron accumulation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208690

T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208690

New advances in iron chelation therapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208690

Neurodegenerative disease and iron storage in the brain

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208690

Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208690

Systemic iron metabolism: a review and implications for brain iron metabolism

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208690

Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208690

Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208690

Selective iron chelation in Friedreich ataxia: biologic and clinical implications.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208690

Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208690

Investigation into the correlation between the structure of hydroxypyridinones and blood-brain barrier permeability.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208690

The pharmacokinetics and blood-brain barrier permeation of the chelators 1,2 dimethly-, 1,2 diethyl-, and 1-[ethan-1'ol]-2-methyl-3-hydroxypyridin-4-one in the rat

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21791473

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3324/HAEMATOL.2011.043018

1 reference

8 August 2017

1 reference

8 August 2017

1 reference